Caraco Pharmaceutical Laboratories Ltd. (CPD)
The Company is engaged in the business of developing, manufacturing, marketing and distributing generic and private-label pharmaceuticals to the wholesalers, distributors, warehousing and non-warehousing chain drugstores and managed care providers.
Recs
Pennyperson
(< 20)
Submitted: 10/27/2009 12:01:10 PM :
Start Price:
$3.89
CPD Score:
+3.12
Recommendation of cap member and/or remembers to at least double with in six months or less
Recs
Roto1177
(75.69)
Submitted: 10/25/2009 8:46:45 PM :
Start Price:
$4.12
CPD Score:
-1.62
CAPS ALL STAR
Recs
PatientTrader
(86.85)
Submitted: 10/15/2009 9:23:46 AM :
Start Price:
$4.67
CPD Score:
-12.80
Small company backed by a 5 billion dollar pharma, which owns around 37% of Caraco.
Recs
SeekBalance
(57.16)
Submitted: 10/14/2009 11:08:42 AM :
Start Price:
$4.80
CPD Score:
-15.29
The FDA's shutdown of CPD's manufacturing operations has scared investors away, but lots of recent capital spending and last week's press release imply that the FDA will allow CPD to resume production sometime soon. Even without manufacturing, CPD has continued to generate a positive operating cash flow as Sun Pharmaceutical's US distributor, and its current cash on hand is about 3.5x debt. So we're pretty safe on the downside, and we can expect a big PPS bump with the resumption of Manufacturing operations.
Recs
expatriot08
(83.84)
Submitted: 10/13/2009 12:14:12 PM :
Start Price:
$4.78
CPD Score:
-34.37
Generics will always be in need and as the Detroit plant gets rolling and once the FDA is on their good side again this stock should be back up closer to the 10 range.
Recs
08PortfolioModel
(< 20)
Submitted: 9/20/2009 9:48:47 PM :
Start Price:
$3.90
CPD Score:
+2.80
Current 4.06, Sept 20 09. Limit 3.91
Recs
Recs
InfiniteCykosis
(68.06)
Submitted: 8/5/2009 2:22:25 PM :
Start Price:
$3.21
CPD Score:
-18.56
As an stockholder in Caraco Pharmaceutical Laboratories Ltd. Research, it pains me to see THREE class action lawsuits filed in the last two weeks. I have received paperwork from two of the firms representing stockholders that believe that CPD has artificially inflated stock prices and tricked investors in the process.
"Kendall Law Group has filed a lawsuit against Caraco Pharmaceutical Laboratories (AMEX: CPD) on behalf of investors who purchased CPD stock that was artificially inflated between May 29, 2008 and June 25, 2009. "
"Shalov Stone Bonner & Rocco LLP announces that a class action lawsuit has been filed on behalf of purchasers of the securities of Caraco Pharmaceutical Laboratories, Ltd. ("Caraco" or the "Company") (AMEX: CPD) between May 29, 2008 and June 25, 2009, inclusive (the "Class Period"). The lawsuit is pending in the United States District Court for the Eastern District of Michigan against Caraco; Daniel H. Movens, Caraco's Chief Executive Officer, and a director; and Mukul Rathi, the Company's Interim Chief Financial Officer. "
"Shalov Stone Bonner & Rocco LLP announced a class action lawsuit has been filed on behalf of purchasers of the securities of Caraco Pharmaceutical Laboratories, Ltd. between May 29, 2008 and June 25, 2009, inclusive (Class Period). The lawsuit is pending in the United States District Court for the Eastern District of Michigan against Caraco; Daniel H. Movens, Caraco's Chief Executive Officer, and a director; and Mukul Rathi, the Company's Interim Chief Financial Officer. The complaint alleges that, throughout the Class Period, the defendants violated the federal securities laws by misrepresenting and failing to disclose material adverse facts."
Lawsuits seem to be common now with Pharmaceutical companies now a days, but that is not a good thing for short term. Potential investors will see these news updates and have little or no interest in buying a few shares, and current stockholders will dump their shares.
Long-term, CPD is a good buy in a marketplace full of different pharmaceutical companies. Short-term, terrible buy due to bad decision making by the board and management.
Recs
220330
(71.76)
Submitted: 7/25/2009 8:27:36 AM :
Start Price:
$3.38
CPD Score:
+8.98
low p/b, low p/s, low debt
Recs
OrangeCrema
(81.72)
Submitted: 7/13/2009 2:57:18 PM :
Start Price:
$3.02
CPD Score:
+13.73
Good entry. See if the Feds don't shut it down
Recs
BigFatBEAR
(99.26)
Submitted: 7/10/2009 11:03:28 AM :
Start Price:
$2.93
CPD Score:
+14.58
Disclosure: haven't done anywhere near sufficient due diligence for CPD, but a lot of the big boys on CAPS are green-thumbed quite a bit higher than here. Risk:reward looks attractive around $3, may pick a little up with real $$, if I learn more about them.
Recs
Trek930SHX
(< 20)
Submitted: 7/9/2009 9:47:47 PM :
Start Price:
$2.83
CPD Score:
+19.53
Strong company that needs to get back on its feet and move forward.
Recs
dragonmonkey
(81.66)
Submitted: 7/9/2009 5:36:29 PM :
Start Price:
$2.83
CPD Score:
+19.53
Some current issues, but current price seems like great entry point. Long term, I like the idea of generic drugs.
Recs
mrindependent
(98.85)
Submitted: 6/29/2009 10:51:27 AM :
Start Price:
$3.08
CPD Score:
+14.50
The FDA is flexing its muscles to show that there is a new sheriff in town. I am not sure how Caraco enraged them to this extent but Caraco has hundreds of millions to gain by fixing the problem.
Recs
aquiline1
(36.24)
Submitted: 6/26/2009 5:54:59 AM :
Start Price:
$4.80
CPD Score:
-36.19
What now? I'll average down if I can get lower than 1.95. Am I crazy? Community let me know. Is this over reaction by FDA? And then over reaction by sellers? I tried to buy more but missed price I wanted.
Don 't know how to calmly buy after hours-- or even frantically. Will anyone give me advise for this generic; and this specific situation? jpr, Aquiline Sorry, not a pitch but don't know where to post this.
Recs
slimjim2005007
(< 20)
Submitted: 6/9/2009 11:32:46 PM :
Start Price:
$4.73
CPD Score:
-30.40
motowns only drug company which is cheap generics
Recs
osucowboys344
(77.62)
Submitted: 6/7/2009 7:25:25 PM :
Start Price:
$4.32
CPD Score:
-22.92
No debt....low pe.....seems good right here
Recs
MSUalum
(86.26)
Submitted: 6/2/2009 9:33:21 PM :
Start Price:
$4.22
CPD Score:
-20.43
Buy when it hits 3. This stock will be back long term.
Recs
DontSellMeShort
(41.37)
Submitted: 6/1/2009 11:15:48 PM :
Start Price:
$4.27
CPD Score:
-21.11
Huge pullback, technically oversold now. Going to watch this closely, maybe buying in tomorrow, actually.
Recs
RSS Headlines
Fool UK
- Show Me:
-
Outperform
-
Underperform
-
All
- Sort by:
-
Author
-
Recs
-
Date
-
Member Rating
-
Results 1 - 20 of 78 1 2 3 4 Next »